press-releases

Lunaphore announces presentations and product demonstrations at the ABRF 2022 Annual Meeting

Lunaphore announces presentations and product demonstrations at the ABRF 2022 Annual Meeting

LAUSANNE, Switzerland – March 8, 2022 – 5:00 pm (CET)Lunaphore, a Swiss life sciences company developing technology to enable spatial biology in every laboratory, today announced several presentations and product demonstrations at the Association of Biomolecular Resource Facilities (ABRF) 2022 Annual Meeting taking place March 28-30, 2022 virtually and in-person in Palm Springs, California. The company presentation will allow core facilities to understand how they can benefit from fully integrated hyperplex spatial biology solutions. A virtual poster presentation will highlight outcomes from a recent study that combined hyperplex imaging on the COMET™ PA platform with machine learning clustering analysis to analyze the tumor microenvironment.

 

Virtual Flash Talk Poster Presentation

Mapping the cellular architecture of the tumor microenvironment by integrating hyperplex immunofluorescence and automated image analysis

Date and time: March 28, 2022, 1:00 p.m. PST | 11:00 p.m. CEST

Speaker: Dr. Pedro Machado Almeida, Application Development Scientist, Lunaphore

The presentation will be available via the official ABRF 2022 Annual Meeting website.

 

Company Presentation

Sample in – image out: hyperplex spatial biology made easy

Date and time: March 30, 2022, 12:15 p.m. PST

Speaker: Dr. James Denegre, Field Application Specialist, Lunaphore

Room: Oasis 1-3

 

Demonstrations

Lunaphore will host live demonstrations of its LabSat® and COMET™  PA spatial biology solutions at booth #105.

 

 

To book a meeting or find out more about Lunaphore’s activities on site, please visit: https://lunaphore.com/news/our-events/lunaphore-at-abrf/

 

 

About Lunaphore

Lunaphore Technologies S.A. is a Swiss company born in 2014 with the vision of enabling spatial biology in every laboratory. Lunaphore has developed a game-changing chip technology which can extract spatial proteomic and genomic data from tumors and transform any simple assay into multiplex spatial biology without complexity. Lunaphore empowers researchers to push the boundaries of research to ultimately develop the next generation personalized therapies. For further information on Lunaphore and its products, please visit www.lunaphore.com.

 

 

For further information contact:

 

Irene Tamayo

Lunaphore Corporate Communications

Email: [email protected]